enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Prediction: These Could Be the Best-Performing Pharma and ...

   www.aol.com/prediction-could-best-performing...

   And I'll make a prediction: The following three players could be the best-performing pharma and biotech stocks through 2030. An investor cheers while sitting in front of a laptop in an office ...

3. Becton, Dickinson and Co Stock Is Estimated To Be ... - AOL

   www.aol.com/news/becton-dickinson-co-stock...

   The stock of Becton, Dickinson and Co (NYSE:BDX, 30-year Financials) is estimated to be fairly valued, according to GuruFocus Value calculation.

4. Prediction: These Could Be the Best-Performing Value ... - AOL

   www.aol.com/prediction-could-best-performing...

   For premium support please call: 800-290-4726 more ways to reach us

5. Prediction: These Could Be the Best-Performing Biotech ... - AOL

   www.aol.com/prediction-could-best-performing...

   Its share price has plunged over 30% this year. Moderna is roughly 86% below its peak set in 2021. However, I think this beaten-down biotech stock could realistically be one of the biggest winners ...

6. Prediction: These 2 Stocks Will Beat the S&P 500 Through 2030

   www.aol.com/prediction-2-stocks-beat-p-131500896...

   For premium support please call: 800-290-4726 more ways to reach us

7. Prediction: These Could Be the Best-Performing Value ... - AOL

   www.aol.com/prediction-could-best-performing...

   But, in light of Morningstar analyst Seth Goldstein's prediction that lithium prices will be 70% higher than they are now by 2030, there's every reason to believe Albemarle's bottom line will ...

8. Here's Why You Should Hold Becton, Dickinson Stock for Now

   www.aol.com/news/heres-why-hold-becton-dickinson...

   For premium support please call: 800-290-4726 more ways to reach us

9. Becton Dickinson shares hit record high after US FDA clears ...

   www.aol.com/news/becton-dickinson-shares-hit...

   Becton's stock rose as high as $287.32, topping the previous intra-day record of $279.38 hit in February 2020. The 510(k) clearance enables the company to resume selling its Alaris infusion system.